The Journal of Medical Toxicology, published by SPRINGER, is a leading interdisciplinary journal dedicated to advancing the understanding of toxicology and its implications in medical practice. With an ISSN of 1556-9039 and an E-ISSN of 1937-6995, this esteemed journal has been a pivotal resource since its inception in 2005, continuing to serve the scientific community through its convergence period lasting until 2024. Its prestigious positioning in the Q2 category in both Health, Toxicology and Mutagenesis, and Toxicology reflects its significant contribution and reputation within the field, recognized by impressive Scopus rankings in Environmental Science and Pharmacology. This journal delves into critical issues surrounding the diagnosis and treatment of toxic exposures, thereby aligning closely with both clinical and public health objectives. Researchers, professionals, and students can benefit from the robust analyses and innovative findings published within its pages, reinforcing the journal's role as an essential platform for knowledge dissemination in medical toxicology.

Aerospace Medicine and Human Performance is an influential journal published by the Aerospace Medical Association, serving as a vital resource for researchers and professionals dedicated to the study of human performance within the realms of aerospace environments. With an ISSN of 2375-6314 and an E-ISSN of 2375-6322, this journal has garnered attention since its inception in 2015 and is dedicated to the dissemination of innovative research, reviews, and case studies that address the complexities of human factors in aviation and space travel. Despite being classified in the Q4 quartile in both Medicine (Miscellaneous) and Public Health, Environmental and Occupational Health categories as of 2023, and its respective Scopus rankings showing opportunities for growth, the journal plays a critical role in bridging gaps in knowledge and promoting advancements in medical practices and safety standards in aerospace contexts. The journal operates under an Open Access model, ensuring that valuable research is readily available to a diverse audience. As it converges into the years up to 2024, it remains committed to enhancing the collaboration and communication within the aerospace medical community.

Integrated Blood Pressure Control is a distinguished Open Access journal published by DOVE MEDICAL PRESS LTD in New Zealand, dedicated to advancing the field of cardiology and cardiovascular medicine as well as internal medicine. With its established timeline from 2009 to 2024, this journal has earned a commendable Q2 ranking in both its categories for 2023, reflecting its significant contribution to clinical research and practice. With an ISSN of 1178-7104, it provides a platform for high-quality, peer-reviewed articles that address the complexities of blood pressure management, aiming to improve patient outcomes and foster discussions among healthcare professionals. The journal's open-access model, implemented since 2008, ensures that research findings are readily available to all, promoting greater accessibility and dissemination of knowledge in this critical area of health. Researchers, professionals, and students alike are encouraged to engage with the latest findings and innovative practices published within this journal, which plays an essential role in shaping the future of blood pressure control and related medical fields.

SAFETY SCIENCE, published by Elsevier in the Netherlands, is a premier international journal dedicated to advancing the fields of safety research, public health, environmental and occupational health, and risk management. With an impressive impact factor and recognized as a Q1 journal in multiple categories for 2023, its rigorous peer-reviewed articles are essential for researchers, professionals, and students alike. The journal covers a wide range of topics designed to influence safety practices and policies globally. Although Open Access options are not available, the substantial insights provided in each issue underscore the journal's critical role in enhancing the understanding of safety and risk dynamics in a constantly evolving world. With a convergence of knowledge from the years 1991 to 2025, SAFETY SCIENCE remains at the forefront of evidence-based research, stimulating essential dialogues and innovations that shape our approach to safety in various domains.

MEDICAL LETTER ON DRUGS AND THERAPEUTICS is a pivotal resource for professionals in the fields of medicine and pharmacology, published by MED LETTER INC. Since its inception in 1965, this journal has been committed to elucidating the complexities of drug therapy and clinical therapeutics, offering readers evidence-based insights and critical evaluations of the latest medications and treatment protocols. With a quarterly ranking reflecting its stature—Q4 in Medicine (Miscellaneous) and Q3 in both Pharmacology and Pharmacology (Medical)—the journal maintains a specific niche ensuring readers are equipped with updated information that continues to influence healthcare practices. Although it does not operate under an open access model, the journal is accessible to institutions and professionals eager to stay at the forefront of medicinal advancements. The importance of this journal lies in its dedication to enhancing pharmacological knowledge, thus catering to the needs of researchers, healthcare providers, and students alike, making it an essential addition to the literature in therapeutic drug interventions.

International Journal of Medical Toxicology and Forensic Medicine, published by Shaheed Beheshti Medical University of Medical Sciences & Health Services, is a pioneering platform dedicated to advancing knowledge within the critical fields of toxicology and forensic medicine. Established as an Open Access journal since 2011, it ensures wide dissemination of research findings, catering to a global audience of researchers, healthcare professionals, and students. With an ISSN of 2251-8762 and an E-ISSN of 2251-8770, the journal covers a diverse range of topics relevant to the medical community, albeit being categorized as Q4 in both Pathology and Forensic Medicine and Toxicology in 2023, indicating emerging significance in these disciplines. Geographically based in Tehran, Iran, it aspires to bridge gaps in scientific research and practice, particularly in regions where such expertise is critical. The journal welcomes submissions that investigate pressing issues in medical toxicology and forensic science, fostering an interdisciplinary dialogue essential for innovative solutions and improved public health outcomes.

Anaesthesia and Intensive Care Medicine, published by Elsevier, is a vital resource in the fields of anesthesiology and critical care, devoted to disseminating innovative research and advancements spanning from 2003 to 2024. With an ISSN of 1472-0299 and an E-ISSN of 1878-7584, this journal provides a platform for healthcare professionals, researchers, and students to engage with a diversity of topics, including pain management, anesthesia techniques, and intensive care protocols. Although it currently holds a category quartile ranking of Q4 in 2023 within both Anesthesiology and Critical Care disciplines, the journal continuously aims to enhance its impact and relevance in the academic community. The journal does not operate on an open-access model, ensuring that subscribers and institutions have exclusive access to high-quality, peer-reviewed research. With its focus on advancing clinical practices and fostering scientific dialogue, Anaesthesia and Intensive Care Medicine is essential for those looking to stay at the forefront of patient care and medical research.

Journal of Radiological Protection, published by IOP Publishing Ltd, is a pivotal academic journal dedicated to advancing knowledge in the fields of radiology and radiation protection. Since its inception in 1988 and continuing through to 2024, this journal provides a platform for the dissemination of innovative research and critical reviews that explore the effects of radiation exposure on health and the environment. With an Impact Factor that places it among the Q3 category in Medicine, Public Health, Environmental and Occupational Health, as well as in Waste Management and Disposal, the journal is vital for professionals, researchers, and students keen on understanding the implications of radiological science. The Journal of Radiological Protection aims to contribute to improved practices and policies in radiation safety, making its findings essential for those involved in environmental health and public safety initiatives. Articles are accessible through various academic databases, ensuring widespread dissemination among the scientific community, thereby enhancing the journal's stature and influence in radiological research.

JOURNAL OF ZOO AND WILDLIFE MEDICINE, published by the American Association of Zoo Veterinarians, serves as a pivotal resource in the field of veterinary science, focusing specifically on the health and well-being of zoo and wildlife species. With an ISSN of 1042-7260 and an E-ISSN of 1937-2825, this journal is recognized for its significant contributions to animal science and has been categorized in the second quartile in both Animal Science and Zoology, as well as Veterinary disciplines, according to the latest rankings. It holds a respectable position within Scopus, being ranked #91 in General Veterinary and #290 in Animal Science and Zoology. While the journal operates on a subscription basis, its impactful research articles have been invaluable for clinicians, researchers, and students alike, providing crucial insights that advance wildlife conservation, veterinary practices, and animal health care from 1993 to the present. With a global reach and a targeted focus on both theoretical and practical applications, JOURNAL OF ZOO AND WILDLIFE MEDICINE is instrumental in fostering collaboration among professionals dedicated to the study and care of wild animal populations.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, published by MARY ANN LIEBERT, INC, stands as a premier academic journal dedicated to advancing the field of pediatric psychopharmacology. With a rich history of publication spanning from 1990 to 2024, this journal presents cutting-edge research that informs clinical practices and policy decisions impacting the mental health of children and adolescents. Ranked in the Q2 category for both Pediatrics, Perinatology and Child Health and Pharmacology (medical) as of 2023, it reflects its critical contribution to these fields, along with a respectable Q3 status in Psychiatry and Mental Health. Researchers and practitioners benefit from the journal's rigorous peer-reviewed articles, which delve into the efficacy, safety, and ethical implications of pharmacological treatments tailored for young populations. Although the journal does not currently offer Open Access, it remains a vital resource for anyone engaged in child and adolescent health research and treatment strategies. Its commitment to fostering dialogue and innovation in psychopharmacology ensures its pivotal role in shaping future standards and practices in this essential area of medical science.